Condition
CIPN - Chemotherapy-Induced Peripheral Neuropathy clinical trials and research
As of November 12, 2026, Find a Trial lists 8 CIPN - Chemotherapy-Induced Peripheral Neuropathy clinical trials that are recruiting, at sites in 6 countries (most in United States (3), United Kingdom (1), Israel (1)). By phase: Phase 2 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 6Countries
Newest CIPN - Chemotherapy-Induced Peripheral Neuropathy clinical trials
All recruiting trials (8)
-
Cryotherapy during weekly paclitaxel to reduce chemotherapy-induced numbness and tingling
This study tests whether applying cryotherapy to hands and feet during weekly paclitaxel helps prevent CIPN in women with breast cancer.
-
Hyperbaric oxygen therapy for nab-paclitaxel-induced neuropathy in breast cancer
This study tests whether hyperbaric oxygen therapy can help relieve neuropathy from nab-paclitaxel in adult women with breast cancer who have finished chemotherapy.
-
Scrambler Therapy for chemotherapy-related nerve pain (CIPN).
Researchers will try Scrambler Therapy, a non-drug electrical treatment, to reduce pain and numbness in people with long-lasting chemotherapy-induced peripheral neuropathy.
-
VMD-3866 topical gel for chemotherapy-induced nerve pain
This trial will test whether a non-opioid topical gel called VMD-3866 can reduce pain in adults with chemotherapy-induced peripheral neuropathy.
-
Cryocompression to prevent taxane-induced nerve damage in the arms and legs.
This study tests whether cooling and pressure applied to the arms and legs during taxane chemotherapy can prevent or reduce numbness, pain, or weakness from peripheral neuropathy in adults with breast or gynecologic cancer.
-
Using Scrambler Therapy with Duloxetine for Chemotherapy-Induced Peripheral Neuropathy
This study is testing if combining Scrambler therapy with duloxetine can help reduce pain in people who have chemotherapy-induced nerve damage.
-
Explicit Sensory Retraining for Chemo-Induced Peripheral Neuropathy
This study tests whether three sessions of explicit sensory retraining for the legs, compared with usual care, can help reduce symptoms and improve function in adults with CIPN after chemotherapy.
-
Using cryotherapy to prevent nerve damage from breast cancer chemotherapy
This study is testing whether using cold therapy during chemotherapy can help prevent nerve damage in women with early-stage breast cancer.
Related topics
Quick answers
How many CIPN - Chemotherapy-Induced Peripheral Neuropathy clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), United Kingdom (1 trial), Israel (1 trial), Denmark (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.